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Abstract: When pathologically externalized, phosphatidylethanolamine (PE)
is a potential surrogate marker for detecting tissue injuries. 99mTc-labeled
duramycin is a peptide-based imaging agent that binds PE with high affinity
and specificity. The goal of the current study was to investigate the clearance
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kinetics of 99mTc-labeled duramycin in a large animal model (normal pigs) and
to assess its uptake in the heart using a pig model of myocardial ischemia–
reperfusion injury.
Methods
The clearance and distribution of intravenously injected 99mTc-duramycin were
characterized in sham-operated animals (n = 5). In a closed chest model of
myocardial ischemia, coronary occlusion was induced by balloon angioplasty
(n = 9). 99mTc-duramycin (10–15 mCi) was injected intravenously at 1 hour
after reperfusion. SPECT/CT was acquired at 1 and 3 hours after injection.
Cardiac tissues were analyzed for changes associated with acute cellular
injuries. Autoradiography and gamma counting were used to determine
radioactivity uptake. For the remaining animals, 99mTc-tetrafosamin scan was
performed on the second day to identify the infarct site.
Results
Intravenously injected 99mTc-duramycin cleared from circulation
predominantly via the renal/urinary tract with an α-phase half-life of
3.6 ± 0.3 minutes and β-phase half-life of 179.9 ± 64.7 minutes. In control
animals, the ratios between normal heart and lung were 1.76 ± 0.21,
1.66 ± 0.22, 1.50 ± 0.20 and 1.75 ± 0.31 at 0.5, 1, 2 and 3 hours postinjection, respectively. The ratios between normal heart and liver were
0.88 ± 0.13, 0.80 ± 0.13, 0.82 ± 0.19 and 0.88 ± 0.14. In vivo visualization
of focal radioactivity uptake in the ischemic heart was attainable as early as
30 min post-injection. The in vivo ischemic-to-normal uptake ratios were
3.57 ± 0.74 and 3.69 ± 0.91 at 1 and 3 hours post-injection, respectively.
Ischemic-to-lung ratios were 4.89 ± 0.85 and 4.93 ± 0.57; and ischemic-toliver ratios were 2.05 ± 0.30 to 3.23 ± 0.78. The size of 99mTc-duramycin
positive myocardium was qualitatively larger than the infarct size delineated
by the perfusion defect in 99mTc-tetrafosmin uptake. This was consistent with
findings from tissue analysis and autoradiography.
Conclusion
99m
Tc-duramycin was demonstrated, in a large animal model, to have suitable
clearance and biodistribution profiles for imaging. The agent has an avid
target uptake and a fast background clearance. It is appropriate for imaging
myocardial injury induced by ischemia/reperfusion.
Keywords: Duramycin; Phosphatidylethanolamine; Ischemia–reperfusion
injury; Apoptosis

1. Introduction
In mammalian cells, the phospholipid bilayer of the plasma
membrane serves as a physical barrier with important biological
functions. The pathological disruption of the bilayer can result in a
scrambled phospholipid distribution with or without membrane
rupturing.1,2 The exposure of aminophospholipids such as
phosphatidylserine (PS) and phosphatidylethanolamine (PE) provides
surrogate markers for detecting tissue injuries. Imaging strategies that
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target scrambled phospholipid bilayer in various tissues have been
widely reported.2,3,4,5,6
There has been a continuous effort to develop positive
radionuclide imaging techniques for detecting ischemic injury in the
cardiovascular system.7 This effort is geared toward a combination of
robust molecular recognition mechanism, an avid target uptake, and a
rapid blood clearance (preferably renal) with a low blood pool and
hepatic background. These criteria are critical for cardiac imaging
applications, because of large bodies of blood pool from adjacent heart
cambers and close vicinity to the liver especially at the apical region of
the heart. Additionally, like most diagnostic imaging procedures, it is
desirable to perform the scan in a timely fashion, preferably shortly
after tracer injection without a prolonged delay. In this regard, the
lantibiotic duramycin is uniquely situated because of its structural
features. Duramycin is currently the smallest known polypeptide that
forms a stereospecific binding pocket.8,9 It has receptor-like binding
behaviors, yet peptide-like clearance kinetics.10,11 Duramycin binds PE
with a high affinity with a Kd reported at around 5 nM.12 It was also
reported that once bound to PE, the binding does not readily dissociate
even in the presence of organic solvent.12 A combination of tight
binding with low molecular weight makes duramycin a candidate of
interest for cardiovascular imaging applications.
The aims of the current study were to evaluate the clearance of
intravenously injected 99mTc-duramycin in healthy pigs and to test the
feasibility of detecting acute myocardial injury in a porcine model of
coronary occlusion/reperfusion. The sarcolemma of cardiomyocytes is
a rich source of PE, which when exposed at the extracellular surface
provides stereospecific and abundant binding targets in conditions
such as ischemic injuries.13 In this work, we present results of studies
with 99mTc-duramycin in a porcine model of ischemia. Since the porcine
cardiovascular system is comparable to that of humans, these studies
provide important data for assessing 99mTc-duramycin as an effective
imaging agent for detecting ischemic injuries in the heart.

2. Materials and methods
Duramycin was covalently modified with succinimidyl 6hydrazinonicotinate acetone hydrazone (HYNIC, Solulink) and purified
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by HPLC as previously reported.10 The molecular weight of HYNIC
modified duramycin was confirmed using matrix-assisted laser
desorption/ionization mass spectrometry. The radiopharmaceutical was
prepared using a single-step kit formulation, where 740–925 MBq (20–
25 mCi) technetium-99 m was injected into duramycin kit vial and
heated for 20 min at 80 °C. Quality control steps, including radioHPLC
and stability tests, were carried out as described before.11,14

2.1. Clearance studies in normal animals
The animal protocol was approved by the Institutional Animal
Care and Use Committee at Nanjing First Hospital affiliated to Nanjing
Medical University and at the Feinberg School of Medicine,
Northwestern University. For characterizing the clearance and
distribution profiles of 99mTc-duramycin, five control animals were
studied. Pigs (M/F, 25–30 kg) were initially anesthetized with
intramuscular injection of ketamine hydrochloride (10 mg/kg).
Anesthesia was maintained using isoflurane. A balloon catheter (length
15 mm, diameter 2.5–3 mm) was delivered into the coronary branches
then withdrawn without inflation as sham operated control. A dose of
99m
Tc-duramycin (370–555 MBq, 10–15 mCi/animal) was injected into
the ear vein. Blood samples were withdrawn for gamma counting
measurements at 0.5, 1, 2, 3, 4, 5, 10, 15, 30, 60, 120 and
180 minutes post-injection. Anterior whole-body planar and SPECT/CT
images were acquired at 0.5, 1, 2 and 3 hr post-injection using a
Symbia TruePoint hybrid SPECT/CT scanner (Siemens). The
parameters for planar imaging were 140 ± 20% keV energy window,
128 x 128 matrix size, 1 million total counts. Parameters for SPECT
included 140 ± 20% keV, with 6 sec acquisition per projection angle.
CT was used for attenuation correction and anatomical coregistration
with SPECT images. Based on blood sample gamma counting
measurements, the biphasic clearance time–activity data were fit to
the following two-exponential equation:

Cb (t) = Ae − t/α + (100 − A)e − t/β
where A and (100 − A) are the factional (%) amplitudes of the two
exponentials with a fast time constant α (fast phase) and a slow time
constant β (slow phase), respectively. The half-lives of the α and β
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phases were then determined by scaling the estimated corresponding
time constants by ln(2).

2.2. Imaging myocardial injury in a porcine model of
coronary occlusion and reperfusion
For the coronary occlusion group, pigs (n = 9, M/F, 25–30 kg)
were anesthetized as described above. A balloon catheter (length
15 mm, diameter 2.5–3 mm) was positioned into one of the following
coronary branches: distal end of the left descending coronary artery
(n = 5), or left circumflex branch (n = 4). Arterial occlusion was
initiated by inflating and maintaining the angioplasty balloon at
8 atmosphere pressure and lasted between 20 and 30 min.
Reperfusion was initiated by deflating and withdrawal of the
angioplasty balloon. Both coronary occlusion and the subsequent
reperfusion were confirmed by angiography. ECG profiles typical of
acute ischemic and reperfusion injury, including arrhythmia and ST
segment depression or elevation, were observed. Levels of cardiac
enzymes, including creatine kinase (CK) and creatine kinase MB
(CKMB), were measured for validation of acute myocardial injury. At
1 hr after reperfusion, 370–555 MBq (10–15 mCi/animal) of 99mTcduramycin was injected into the ear vein, anterior whole-body planar
images were acquired at 0.5 hour post-injection. SPECT/CT images
were acquired at 1 and 3 hr post-injection. Perfusion imaging was
performed on the second day, at 45 min after an intravenous injection
of 99mTc-tetrofosmin (370–555 MBq, 10–15 mCi/animal). Imaging data
were reconstructed and processed with attenuation correction based
on the acquired CT data using software provided by the manufacturer
(Syngo, Siemens). SPECT data localization was validated using CT
anatomical coregistration. Radioactivity uptake in regions of interests
was determine at 1 and 3 hours post-injection for the myocardial wall,
lung and liver in terms of counts/voxel/min. Uptake ratios between
heart/lung and heart/liver were subsequently calculated.

2.3. Tissue analysis
Representative cardiac tissue specimens were harvested from
the ischemic core and periphery for analysis. To quantitatively
examine the extent of DNA damage of each cell, we performed flow
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cytometric analysis on cardiac cells isolated from separate tissue
specimens. Cardiac tissues were dissected into small pieces, and were
gently pressed through a fine mesh. The cells were fixed, stained with
Propidium Iodide and analyzed by flow cytometry. The presence of
cells with sub-G0 DNA content was determined. This procedure was
performed in 3 independent measurements using tissues from 3
different animals. Hematoxylin and eosin (H&E) staining was
performed on cryosections. For ultrastructural examination, ultrathin
sections were cut from core ischemic tissues on an Ultracut
ultramicrotome (Mager Scientific Inc., Dexter, MI), mounted on mesh
copper grids, and poststained in uranyl acetate and Reynold's lead
citrate. The sections were examined using a transmission electronic
microscope (JEM-1010). The presence of apoptosis was determined
using tissues harvested from the periphery of ischemic regions. DNA
fragmentation was analyzed by terminal deoxynucleotidytransferase
mediated dUTP nick-end labeling (TUNEL) assay using a commercial kit
(Maxin-Bio) according the manufacturer's protocol on 8 μm
cryosections. TUNEL-positive nuclei as a percentage of total nuclei was
determined and used as the apoptotic index.

2.4. Statistical analysis
All data were expressed as mean ± standard deviation;
statistical analysis was performed using Student's t-test, where a P
value of less than 0.05 was considered statistically significant.

3. Results
3.1. In vivo kinetic studies in normal pigs
The radiopharmaceutical dose consistently had a radiochemical
purity at 90% or greater, and was stable without significant presence
of dissociated radioactivity. After intravenous injection, 99mTcduramycin cleared from the blood circulation with predominantly renal
excretion, leaving a low systemic background including the blood pool
and liver. The blood clearance profile of 99mTc-duramycin in control
animals is shown in Fig. 1A. The half-life for the fast clearance phase
(α-phase), which accounted for 77.6% ± 5.5% of blood activity, was
estimated to be 3.6 ± 0.3 minutes (n = 5). The half-life for the slow
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clearance phase (β-phase) was estimated to be 179.9 ± 64.7 minutes
(n = 5). According to the SPECT data, the radioactivity uptake levels in
terms of counts/voxel/min in normal heart, lung and liver, and their
dynamic clearance profiles are shown in Fig. 1B. The ratios between
normal heart and lung were 1.76 ± 0.21, 1.66 ± 0.22, 1.50 ± 0.20
and 1.75 ± 0.31 at 0.5, 1, 2 and 3 hours post-injection, respectively.
The ratios between normal heart and liver were 0.88 ± 0.13,
0.80 ± 0.13, 0.82 ± 0.19 and 0.88 ± 0.14. Representative whole-body
anterior planar images acquired at 0.5, 1, 2 and 3 hours post-injection
are shown in Fig. 1C. The time series of planar images are presented
with the same threshold and scale bar. Apart from the bladder signal,
the cardiac blood pool and liver background was visible at 30 minutes
after 99mTc-duramycin injection. These signals diminished over time to
near background levels.

Fig. 1. 99mTc-duramycin clearance and distribution in control animals. (A) Blood
clearance profile as a function of time. Solid line: two-exponential fitting for estimation
of blood clearance half-lives. (B) Organ clearance profiles derived from serial SPECT
data, for the heart (○), lung (■) and liver (▲) as a function of time. (C) Serial anterior
whole-body planar images acquired at 30, 60, 120 and 180 minutes after intravenous
99mTc-duramycin injection.
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3.2. In vivo imaging in a porcine model of myocardial
ischemia and reperfusion
In animals that experienced myocardial ischemia and
reperfusion, the presence of tissue injuries was confirmed by cardiac
enzyme tests. CK level elevated from 310.3 ± 23.2 to
1793.4 ± 1451.6 (P = 0.045), and CKMB level increased from
44.0 ± 5.4 to 661.2 ± 281.3 (P < 0.01). Focal uptake at the ischemic
site was clearly discernible in planar whole-body scans as early as
30 minutes after injection (Fig. 2A). In contrast, this was absent in
control animals but only a diffused blood pool background (Fig. 1C). In
SPECT images acquired at 1 hour post-injection, a prominent hot spot
at the ischemic myocardium in the anterior left free wall was
detectable, as seen in representative images (Fig. 2B and C).
Radioactivity uptake in the remote, normal myocardium was at
background. Signals from the blood pool in heart chambers were
minimal. At 3 hours post-injection, the focal uptake remained
conspicuous without washout (Fig. 3A and B). In 99mTc-tetrafosamin
scan acquired on day 2 the perfusion deficiency was found at the same
location as the 99mTc-duramycin hotspot, but appeared to be smaller in
size upon visual inspection of the images (Fig. 3C and D). Of the 9
animals enrolled, 5 had myocardial ischemia in the left anterior
coronary branch, and the remaining 4 had occlusion at the circumflex
territory. Hot spot radioactivity uptake unambiguously identified all
ischemic regions. An additional example, taken at 1 hr post-injection
from an animal with a relatively small region of myocardial ischemia at
the distal region in the circumflex territory, is shown in Fig. 4. Overall,
signals at the focal uptake in ischemic regions were significantly above
background. The ischemic-to-remote uptake ratios were 3.57 ± 0.74
and 3.69 ± 0.91 at 1 and 3 hours post-injection, respectively.
Ischemic-to-lung ratios were 4.89 ± 0.85 and 4.93 ± 0.57, at 1 and
3 hours, respectively. Over the same period, there was a significant
improvement in ischemic-to-liver ratios, from 2.05 ± 0.30 to
3.23 ± 0.78 (P < 0.05). No adverse effect associated with the injected
radiopharmaceutical was seen.
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Fig. 2. Imaging ischemic myocardial injury using 99mTc-duramycin in a pig model of
myocardial ischemia and reperfusion. (A) Whole-body anterior planar image acquired
at 30 minutes post-injection. Radioactivity uptake in the ischemic heart region can be
differentiated from the background, as marked by an arrow. Injection site via the ear
vein is marked with an asterisk. Left and right kidneys are labeled as KL and KR,
respectively. The bladder is marked as BL. (B and C) Short- and long-axial SPECT/CT
fusion images acquired at 1 hour post-injection, with a hot spot 99mTc-duramycin
uptake at the anterior left ventricular free wall (arrow). (D and E) Short- and longaxial images acquired at 3 hours from the same animal. Consecutive slices are shown
in Supplementary Fig. 1 and Supplementary Fig. 2, for 1 and 3 hour data,
respectively.
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Fig. 3. A representative example of a relatively small, apical region of ischemic injury
detected in SPECT/CT using 99mTc-duramycin. (A) Short-axial CT of the thorax. (B and
C) A small area of ischemic and reperfusion injury was identified (arrows) at the apical
region of the heart as a result of distal circumflex occlusion.
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Fig. 4. Imaging small region of acute ischemic myocardial injury using 99mTcduramycin. (A) Short-axial CT of the thorax. (B and C) A small area of ischemic and
reperfusion damage is identified (arrows) at the apical region of the heart as a result
of distal circumflex occlusion.

3.3. Post-mortem tissue analysis
The localization of radioactivity uptake in ischemic tissue was
examined in post-mortem analysis. As shown in Fig. 5A, the location of
hot spot radioactivity uptake was consistent with the perfusion
territory of occluded coronary branch. The presence of high
radioactivity was localized at TTC-deficient, infarcted myocardium as
well as border regions. The total area positive for radioactivity was
visually larger than the size of total infarcted (TTC-negative) tissues.
These measurements were consistent with visibly larger 99mTc-
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duramycin-positive regions in vivo versus perfusion defects in 99mTctetrofosmin scan. The percentage of nuclei with DNA damage
characteristic of apoptotic cells in ischemic myocardium, as shown by
TUNEL assay (Fig. 5B), was 28.04% ± 3.25% versus a baseline of
3.49% ± 1.83% in normal myocardium (P < 0.001). This was
accompanied with a rise in cells at sub-G0 phase (4.62% ± 1.96%
versus 0.50% ± 0.23% in normal myocardium, P = 0.022), which
reflects necrotic cells that had reduced nucleic acid content due to
compromised plasma membrane and cellular integrity. The relatively
high percentage of apoptotic and necrotic cells was consistent with
ischemic/reperfusion injury. Ultrastructural changes associated with
ischemic tissue damages were documented using transmission electron
microscopy, where features that are typical of apoptotic and necrotic
cell death are present, including cytoplasm shrinkage, nuclear
condensation and marginalization, and mitochondrial deformation
(Fig. 5C). The presence of fragmented nuclei, myofibril degeneration
and local hemorrhage, which are typical changes associated with
ischemic injuries, are detected in H&E stained tissue sections
(Fig. 5D).
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Fig. 5. Histological analyses. (A) TTC stained (upper) and autoradiography (lower) of
the same short-axial heart sections. (B) TUNEL staining of tissue harvested from the
periphery of the ischemic core. (C) Ultrastructural changes associated with
ischemia/reperfusion injury, as identified with transmission electron microscopy. (D)
H&E staining of damaged myocardium at the ischemic zone.

4. Discussion
There are a number of significant findings from the current
investigation. As demonstrated in a large animal model, the in vivo
clearance profile of 99mTc-duramycin is appropriate for imaging in the
cardiovascular system. An avid uptake in the target tissue combined
with a low background enabled the noninvasive imaging of
ischemic/reperfusion myocardial injury in the acute phase as early as
30 minutes after injection. In addition to an uptake in infarcted
myocardium, 99mTc-duramycin binding to ischemic-but-noninfarct
tissues indicated that it was effective in detecting ischemically injured
myocardium.
Molecular features of 99mTc-duramycin are unique for having
both a robust binding mechanism and a favorable clearance profile.
Antibodies and larger proteins have exquisite binding properties but
suboptimal clearance for in vivo imaging. On the other hand, while
short peptides in general have superior pharmacokinetics, they lack
structurally-defined binding modules such as that of immunoglobulin
fold. The underlying conundrum is that a strong molecular recognition
mechanism requires a well-defined binding structure, which often
necessitates extensive scaffolding only afforded in large proteins.
Currently, the roles of peptide-based imaging agents are
predominantly confined to ligands that are recognized and sequestered
by cognate receptors. The molecular features of duramycin combine
the two extremes in the spectrum of binding-versus-size relationship.
The overall structure of duramycin with a stereospecific binding pocket
is accomplished with only 19 amino acids (molecular weight 2 kDa),
making duramycin and its structural derivatives uniquely situated for
imaging applications.
With accumulating evidence, the pathological externalization of
PE is being established as an imaging marker for tissue/cellular
injuries.10,11,15,16,17 The sarcolemma of cardiomyocytes is a rich source
of PE, which when externalized to the cell surface constitutes an
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abundant molecular target. In contrast to conventional infarct-avid
imaging approaches, membrane phospholipid scrambling occurs in
both apoptosis and necrosis. In cells under severe ischemia, their
ability to maintain proper phospholipid asymmetry is compromised,
and the transbilayer redistribution of aminophospholipids provides an
additional source of target for detection.18,13,19 As such, membrane
phospholipid scrambling as a biomarker reflects global injury instead of
infarction per se. This was consistent with the current finding where
the myocardial region positive for 99mTc-duramycin uptake was visually
more expansive than the infarct alone. When fully established, the
ability to accurately assess the full extent of myocardial injury is likely
to lead to a better diagnostic marker for ischemic coronary syndromes,
with prognostic predictive value for adverse cardiac events like heart
failure and the risk for arrhythmia.

5. Conclusion
The clearance of intravenously injected 99mTc-duramycin was
predominantly via the renal/urinary tract with relatively low systemic
and hepatic background in a large animal model. These in vivo
properties were suitable for imaging applications for the cardiovascular
system. Data from the porcine model of myocardial ischemia and
reperfusion indicated that the uptake of 99mTc-duramycin enabled the
detection of ischemically-injured myocardial tissues effectively.

Conflict of interest statement
The authors declare that they have no conflict of interest.

Acknowledgment
This research was supported by grants from National Natural Science
Foundation of China (81171383, 81071176, 81371586, 91229127,
81070194), Department of Veterans Affairs, and the National Institute of
Health (1R01HL102085).

Nuclear Medicine and Biology, Vol 41, No. 2 (February 2015): pg. 198-204. DOI. This article is © Elsevier and permission
has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

15

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

References
P. Williamson, R.A. Schlegel. Transbilayer phospholipid movement and the
clearance of apoptotic cells. Biochim Biophys Acta, 1585 (2002), pp.
53–63
2
K. Emoto, N. Toyama-Sorimachi, H. Karasuyama, et al. Exposure of
phosphatidylethanolamine on the surface of apoptotic cells. Exp Cell
Res, 232 (1997), pp. 430–434
3
M. Zhao, X. Zhu, S. Ji, et al. 99mTc-labeled C2A domain of synaptotagmin I
as a target-specific molecular probe for noninvasive imaging of acute
myocardial infarction. J Nucl Med, 47 (2006), pp. 1367–1374
4
J.F. Tait, C. Smith, F.G. Blankenberg. Structural requirements for in vivo
detection of cell death with 99mTc-annexin V. J Nucl Med, 46 (2005),
pp. 807–815
5
L. Hofstra, I.H. Liem, E.A. Dumont, et al. Visualisation of cell death in vivo in
patients with acute myocardial infarction. Lancet, 356 (2000), pp.
209–212
6
F.G. Blankenberg, P.D. Katsikis, J.F. Tait, et al. In vivo detection and
imaging of phosphatidylserine expression during programmed cell
death. Proc Natl Acad Sci U S A, 95 (1998), pp. 6349–6354
7
A. Flotats, I. Carrió. Non-invasive in vivo imaging of myocardial apoptosis
and necrosis. Eur J Nucl Med Mol Imaging, 30 (2003), pp. 615–630
8
F. Hayashi, K. Nagashima, Y. Terui, et al. The structure of PA48009: the
revised structure of duramycin. J Antibiot (Tokyo), 43 (1990), pp.
1421–1430
9
N. Zimmermann, S. Freund, A. Fredenhagen, et al. Solution structures of
the lantibiotics duramycin B and C. Eur J Biochem, 216 (1993), pp.
419–428
10
M. Zhao, Z. Li, S. Bugenhagen. 99mTc-labeled duramycin as a novel
phosphatidylethanolamine-binding molecular probe. J Nucl Med, 49
(2008), pp. 1345–1352
11
S. Audi, Z. Li, J. Capacete, et al. Understanding the in vivo uptake kinetics
of a phosphatidylethanolamine-binding agent (99 m)Tc-duramycin.
Nucl Med Biol, 39 (2012), pp. 821–825
12
K. Iwamoto, T. Hayakawa, et al. Curvature-dependent recognition of
ethanolamine phospholipids by duramycin and cinnamycin. Biophys J,
93 (2007), pp. 1608–1619
13
J.A. Post, A.J. Verkleij, G.A. Langer. Organization and function of
sarcolemmal phospholipids in control and ischemic/reperfused
cardiomyocytes. J Mol Cell Cardiol, 27 (1995), pp. 749–760
14
M. Zhao, Z. Li. A single-step kit formulation for the (99 m)Tc-labeling of
HYNIC-Duramycin. Nucl Med Biol, 39 (2012), pp. 1006–1011
1

Nuclear Medicine and Biology, Vol 41, No. 2 (February 2015): pg. 198-204. DOI. This article is © Elsevier and permission
has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

16

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.
15

16

17

18

19

A.V. Clough, S.H. Audi, S.T. Haworth, D.L. Roerig. Differential lung uptake
of 99mTc-hexamethylpropyleneamine oxime and 99mTc-duramycin in the
chronic hyperoxia rat model. J Nucl Med, 53 (2012), pp. 1984–1991
Y. Zhang, G.D. Stevenson, C. Barber, L.R. Furenlid, H.H. Barrett, J.M.
Woolfenden, et al. Imaging of rat cerebral ischemia–reperfusion injury
using(99 m)Tc-labeled duramycin. Nucl Med Biol, 40 (2013), pp. 80–
88
S.E. Johnson, Z. Li, Y. Liu, J.E. Moulder, M. Zhao. Whole-body imaging of
high-dose ionizing irradiation-induced tissue injuries using 99mTcduramycin. J Nucl Med, 54 (2013), pp. 1397–1403
R.J. Musters, E. Otten, E. Biegelmann, J. Bijvelt, J.J. Keijzer, J.A. Post, et
al. Loss of asymmetric distribution of sarcolemmal
phosphatidylethanolamine during simulated ischemia in the isolated
neonatal rat cardiomyocyte. Circ Res, 73 (1993), pp. 514–523
H. Kenis, H.R. Zandbergen, L. Hofstra, et al. Annexin A5 uptake in ischemic
myocardium: demonstration of reversible phosphatidylserine
externalization and feasibility of radionuclide imaging. J Nucl Med, 51
(2010), pp. 259–267

Correspondence to: B. Zhu, Department of Nuclear Medicine, Wuxi People's
Hospital Affiliated to Nanjing Medical University, 299 Qingyang Road, Wuxi
214023, China. Tel.:+86 510 85350384.
Correspondence to: H. Zhu, State Key Laboratory of Bioactive Substance
and Function of Natural Medicines, Institute of Materia Medica, Peking Union
Medical College & Chinese Academy of Medical Sciences, Xiannongtan Road,
Beijing 100050, China. Tel.: + 86 10 63188106.
Correspondence to: M. Zhao, Feinberg Cardiovascular Research Institute,
Department of Medicine, Northwestern University, 303 E. Chicago Avenue,
Chicago, IL 60611, USA. Tel.: + 1 312 503 3226.

Nuclear Medicine and Biology, Vol 41, No. 2 (February 2015): pg. 198-204. DOI. This article is © Elsevier and permission
has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Elsevier.

17

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

The following are the supplementary data related to this article.

Supplementary Fig. 1.

Consecutive slices in axial, sagittal and coronal SPECT/CT data acquired at 1 hr post
injection.
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Supplementary Fig. 2.

Consecutive slices in axial, sagittal and coronal SPECT/CT data acquired at
3 hr post injection.
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